Not applicableLooking for participantsNCT03417336
What this trial is testing
Study Evaluating the Efficacy and the Tolerance of Pelvic-prostatic Hypo-fractionated Radiotherapy Followed by Boost in Patients With Prostate Adenocarcinoma Adverse Intermediate Risk or High Localized Risk
Who this might be right for
To Evaluate the Rate of Digestive and Urinary Toxicity
Centre Georges Francois Leclerc 90